Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?4.0 RB, SLA? 10mm, RXD: medical device reports filed with FDA

2,778 reports name it, 2020–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,778
device reports naming the brand
0% of all MAUDE reports · about 477 a year
889
reports, 12 months to August 2026
707 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,778 medical device reports received by FDA name the brand "BLX ?4.0 RB, SLA? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

889 reports arrived in the 12 months to August 2026, up 26% from 707 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.8%), loss of osseointegration (16.3%) and difficult to insert (1.3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

089177Sep 2021: 9Oct 2021: 12Nov 2021: 15Dec 2021: 62022Jan 2022: 11Feb 2022: 15Mar 2022: 12Apr 2022: 24May 2022: 12Jun 2022: 19Jul 2022: 29Aug 2022: 14Sep 2022: 22Oct 2022: 26Nov 2022: 23Dec 2022: 322023Jan 2023: 21Feb 2023: 40Mar 2023: 32Apr 2023: 34May 2023: 45Jun 2023: 24Jul 2023: 38Aug 2023: 40Sep 2023: 25Oct 2023: 44Nov 2023: 39Dec 2023: 422024Jan 2024: 36Feb 2024: 49Mar 2024: 48Apr 2024: 65May 2024: 58Jun 2024: 55Jul 2024: 56Aug 2024: 61Sep 2024: 50Oct 2024: 35Nov 2024: 45Dec 2024: 582025Jan 2025: 47Feb 2025: 32Mar 2025: 63Apr 2025: 37May 2025: 0Jun 2025: 177Jul 2025: 99Aug 2025: 64Sep 2025: 51Oct 2025: 60Nov 2025: 67Dec 2025: 982026Jan 2026: 77Feb 2026: 53Mar 2026: 87Apr 2026: 90May 2026: 79Jun 2026: 66Jul 2026: 91Aug 2026: 70

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03987952020: 1120202021: 8020212022: 23920222023: 42420232024: 61620242025: 79520252026: 6132026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,778
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report83.8%2,327
Voluntary report0%0
User facility report0%0
Distributor report16.2%451
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,04973.8%62.8%
Loss of osseointegration45416.3%22.4%
Difficult to insertthe device was hard to insert361.3%0.4%
Fracturea broken bone60.2%1.6%
Separation failure20.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis94734.1%
Painpain, site not specified57520.7%
Inflammationinflammation1676%
Swelling/ edema1485.3%
Hemorrhage/blood loss/bleeding1374.9%
Hyperresponsive to stimuli722.6%
Fistula632.3%
Abscessa collection of pus602.2%
Hypersensitivity/allergic reaction371.3%
Sinus perforation130.5%
Numbnessnumbness100.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?4.0 RB, SLA? 10mm, RXDProduct code DZEAll MAUDE reports
Reports2,7783,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer83.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?4.0 RB, SLA? 10mm, RXD reports

How many FDA reports name BLX ?4.0 RB, SLA? 10mm, RXD?

2,778 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 889 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.8%), loss of osseointegration (16.3%), difficult to insert (1.3%), fracture (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (83.8%) and distributor reports (16.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?4.0 RB, SLA? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.